Intrinsic Value

The intrinsic value of Oxford Biodynamics PLC (LMQ) under the Base Case is 0.0002 EUR per share. Compared with the current market price of 0.0005 EUR, the stock appears Overvalued by 60% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

LMQ Intrinsic Value
€0.0002
Overvaluation 60%
Intrinsic Value
Price €0.0005
Alert me when LMQ is below its intrinsic value
Today €0.0002 · 67.9% below the current price

LMQ is cheaper than usual. Still overvalued, but less so than on 90% of days in the past 5 years.

Alternatives to LMQ

Fundamental Analysis

What Oxford Biodynamics Does

Life Sciences Tools & Services Health Care

Oxford Biodynamics is a biotechnology company that develops blood-based tests using its EpiSwitch platform, which looks at how DNA is folded in the cell to find disease signals. The company’s core work is to discover and validate biomarkers that can help identify cancer and other serious diseases earlier or more accurately than standard tests.

Headquarters
United Kingdom UK
Employees
41
IPO date
Dec 6, 2016
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue LMQ Research

Decided on Oxford Biodynamics? Get an email when LMQ reaches the price you’d buy at. Free with an account.

Other Oxford Biodynamics listings

What is the Intrinsic Value of one LMQ stock?

The intrinsic value for Oxford Biodynamics PLC (LMQ) under the Base Case is 0.0002 EUR.

Is LMQ stock undervalued or overvalued?

Compared with the current market price of 0.0005 EUR, the stock appears Overvalued by 60% .

How reliable are our estimates? See how past valuations played out
Back to Top